Pfizer targets $7.7B in operational efficiency savings by 2027, highlights strategic R&D shifts

Earnings Call Insights: Pfizer Inc. (PFE) Q1 2025

Management View

  • CEO Dr. Albert Bourla discussed Pfizer’s strategic focus on improving R&D productivity, emphasizing a disciplined approach to advancing its pipeline. The company highlighted the discontinuation of danuglipron development as part of its strategic

Leave a Reply

Your email address will not be published. Required fields are marked *